Activity of pazopanib in <i>EWSR1-NFATC2</i> translocation-associated bone sarcoma.

Gouda, Mohamed A; Zarzour, Maria A; Vaporciyan, Ara A; Kairemo, Kalevi; Chuang, Hubert H; Subbiah, Vivek

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.

Gouda, Mohamed A; Zarzour, Maria A; Vaporciyan, Ara A; Kairemo, Kalevi; Chuang, Hubert H; Subbiah, Vivek.

Affiliation

Gouda MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Vaporciyan AA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Kairemo K; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Chuang HH; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Oncoscience ; 10: 44-53, 2023.

Article de En | MEDLINE | ID: mdl-37736255

Mots clés

pazopanib; precision oncology; sarcoma

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Oncoscience Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google